Evaluate the Efficacy of Sorafenib in Renal Cell Carcinoma Patients After a Radical Resection of the Metastases

The recruitment status of this study is unknown because the information has not been verified recently.

Verified March 2014 by Fondazione IRCCS Istituto Nazionale dei Tumori, Milano.
Recruitment status was Recruiting

Sponsor:

Information provided by (Responsible Party):

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

ClinicalTrials.gov Identifier:

NCT01444807

First received: September 8, 2011

Last updated: March 26, 2014

Last verified: March 2014

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	September 2016
Estimated Primary Completion Date:	September 2015 (Final data collection date for primary outcome measure)